These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2. Lee SH; Yun S; Piao ZH; Jeong M; Kim DO; Jung H; Lee J; Kim MJ; Kim MS; Chung JW; Kim TD; Yoon SR; Greenberg PD; Choi I J Immunol; 2010 Jul; 185(2):917-28. PubMed ID: 20543098 [TBL] [Abstract][Full Text] [Related]
7. Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions. Hennessy RJ; Pham K; Delconte R; Rautela J; Hodgkin PD; Huntington ND J Leukoc Biol; 2019 Jun; 105(6):1341-1354. PubMed ID: 31079418 [TBL] [Abstract][Full Text] [Related]
8. Suppressor of cytokine signaling (SOCS) proteins are induced by IL-7 and target surface CD127 protein for degradation in human CD8 T cells. Ghazawi FM; Faller EM; Parmar P; El-Salfiti A; MacPherson PA Cell Immunol; 2016; 306-307():41-52. PubMed ID: 27423467 [TBL] [Abstract][Full Text] [Related]
9. Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8 Kwaa AKR; Talana CAG; Blankson JN J Virol; 2019 Feb; 93(3):. PubMed ID: 30404799 [TBL] [Abstract][Full Text] [Related]
10. Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity. Alice AF; Kramer G; Bambina S; Baird JR; Bahjat KS; Gough MJ; Crittenden MR J Immunol; 2018 Jan; 200(1):177-185. PubMed ID: 29150567 [TBL] [Abstract][Full Text] [Related]
11. [Role of dendritic cells in the modulation of innate effectors of immunity]. Terme M; Masurier C; Fernandez N; Lacassagne MN; Marolleau JP; Zitvogel L Pathol Biol (Paris); 2001 Jul; 49(6):475-7. PubMed ID: 11484608 [TBL] [Abstract][Full Text] [Related]
12. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells. Kim N; Kim HS Front Immunol; 2018; 9():2041. PubMed ID: 30250471 [TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma. Görgün G; Calabrese E; Soydan E; Hideshima T; Perrone G; Bandi M; Cirstea D; Santo L; Hu Y; Tai YT; Nahar S; Mimura N; Fabre C; Raje N; Munshi N; Richardson P; Anderson KC Blood; 2010 Oct; 116(17):3227-37. PubMed ID: 20651070 [TBL] [Abstract][Full Text] [Related]
14. Immunomodulation of NK Cell Activity. Domaica CI; Sierra JM; Zwirner NW; Fuertes MB Methods Mol Biol; 2020; 2097():125-136. PubMed ID: 31776924 [TBL] [Abstract][Full Text] [Related]
15. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures. Sabry M; Zubiak A; Hood SP; Simmonds P; Arellano-Ballestero H; Cournoyer E; Mashar M; Pockley AG; Lowdell MW PLoS One; 2019; 14(6):e0218674. PubMed ID: 31242243 [TBL] [Abstract][Full Text] [Related]
17. NK Cell Priming From Endogenous Homeostatic Signals Is Modulated by CIS. Delconte RB; Guittard G; Goh W; Hediyeh-Zadeh S; Hennessy RJ; Rautela J; Davis MJ; Souza-Fonseca-Guimaraes F; Nunès JA; Huntington ND Front Immunol; 2020; 11():75. PubMed ID: 32082327 [TBL] [Abstract][Full Text] [Related]
18. Suppressors of cytokine signaling inhibit effector T cell responses during Mycobacterium tuberculosis infection. Srivastava V; Vashishta M; Gupta S; Singla R; Singla N; Behera D; Natarajan K Immunol Cell Biol; 2011 Oct; 89(7):786-91. PubMed ID: 21537342 [TBL] [Abstract][Full Text] [Related]
19. NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines. Jaime-Ramirez AC; McMichael E; Kondadasula S; Skinner CC; Mundy-Bosse BL; Luedke E; Jones NB; Mani A; Roda J; Karpa V; Li H; Li J; Elavazhagan S; La Perle KM; Schmitt AC; Lu Y; Zhang X; Pan X; Mao H; Davis M; Jarjoura D; Butchar JP; Poi M; Phelps M; Tridandapani S; Byrd JC; Caligiuri MA; Lee RJ; Carson WE Cancer Immunol Res; 2016 Apr; 4(4):323-336. PubMed ID: 26865456 [TBL] [Abstract][Full Text] [Related]
20. CIS is a potent checkpoint in NK cell-mediated tumor immunity. Delconte RB; Kolesnik TB; Dagley LF; Rautela J; Shi W; Putz EM; Stannard K; Zhang JG; Teh C; Firth M; Ushiki T; Andoniou CE; Degli-Esposti MA; Sharp PP; Sanvitale CE; Infusini G; Liau NP; Linossi EM; Burns CJ; Carotta S; Gray DH; Seillet C; Hutchinson DS; Belz GT; Webb AI; Alexander WS; Li SS; Bullock AN; Babon JJ; Smyth MJ; Nicholson SE; Huntington ND Nat Immunol; 2016 Jul; 17(7):816-24. PubMed ID: 27213690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]